No Data
No Data
Express News | Smith+Nephew Announces FDA 510(k) Clearance For Its New CATALYSTEM Primary Hip System
Best-in-class Just Got Better; Smith+Nephew Announces 510(k) Clearance of New CATALYSTEM Primary Hip System
Engineered for precision, confidence and efficiency in surgery - and compatible with the CORI◊ Surgical System Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received
Smith & Nephew (SN) Receives a Buy From UBS
European Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading
European equities traded in the US as American depositary receipts opened the week trending lower late Monday morning, declining 0.37% to 1,463.52 on the S&P Europe Select ADR Index.From continental
AlphaValue/Baader Europe Downgrades Smith & Nephew to Add, Trims PT
AlphaValue/Baader Europe on Monday downgraded its rating on medical technology group Smith & Nephew (SN.L) to add from buy and reduced its price target to 13.55 pounds sterling from 13.82 pounds.
Activist Cevian Has a Stake in Medical Device Company Smith & Nephew. How It May Help Improve Margins
British company Smith & Nephew is already a global leader in medical tech. Cevian could help it boost its profitability.